兽用疫苗开发流程图助力新疫苗研发
英国政府2015年设立英国疫苗网络以应对新发疾病威胁,工作组先制作人用疫苗开发流程图,鉴于动物福利和人兽共患病影响又制作兽用疫苗开发流程图。本文描述该图的制作,涵盖从目标产品概况(TPP)到发现与可行性、产品开发与注册的全过程。
要点
- 兽用疫苗开发流程图覆盖从TPP到注册的全过程
- 流程图旨在识别快速应对疫情中的瓶颈
- 人兽共患病防控需要兽用疫苗开发支持
核心结论
- 兽用疫苗开发流程图可辅助新疫苗开发并识别快速应对疫情中的瓶颈。
研究设计与样本
- 本文描述兽用疫苗开发流程图的制作,覆盖从目标产品概况(TPP)到发现与可行性、产品开发与注册的过程。
主要发现
- 英国疫苗网络关注新发疾病威胁下疫苗开发的瓶颈。
- 工作组先制作人用疫苗开发流程图,后因动物福利和人兽共患病影响制作兽用疫苗开发流程图。
临床怎么用
- 可参考该流程图理解兽用疫苗从TPP到注册的开发环节与潜在瓶颈。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The UK Government recognised the importance of vaccines in the control of new emerging disease threats and in 2015 established the UK Vaccine Network to focus on specific areas of need. One of these was the understanding of what is involved in the development of a new vaccine and what are the potential bottlenecks to a rapid response in the face of an epidemic such as Ebola, MERS and more recently COVID-19. A Working Group was established to initially produce a Vaccine Development Process Map for a Human Vaccine. However, in view of the importance of animal wellbeing and the significant impact of diseases with Zoonotic potential, a similar Map has been created outlining the Veterinary Vaccine Development Process. This paper describes the production of that Map and covers the process from the generation of a Target Product Profile (TPP) through Discovery and Feasibility, and on to Product Development and Registration.
引用
- Francis MJ. A Veterinary Vaccine Development Process Map to assist in the development of new vaccines. Vaccine. 2020. PMID: 32418794. doi:10.1016/j.vaccine.2020.05.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。